WEST PHARMA DRN financial statements, including revenue, expenses, profit, and loss

The total revenue of W2ST34 for the last quarter is 4.14 B BRL, and it's 13.18% higher compared to the previous quarter. The net income of Q3 24 is 754.20 M BRL.